In the current study DM, lipids, HSI, APRI, FIB4 scores and CC genotype of ABCA1 rs1800977 (p < .05) had been defined as the main factors affecting fibrosis progression in NAFLD patients. The gene discussed is ABCA1; the disease is metabolic dysfunction-associated steatotic liver disease.